Cover Image
市場調查報告書

呼吸疾病檢驗的全球市場:2015∼2019年

Global Respiratory Disease Testing Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 345192
出版日期 內容資訊 英文 66 Pages
訂單完成後即時交付
價格
Back to Top
呼吸疾病檢驗的全球市場:2015∼2019年 Global Respiratory Disease Testing Market 2015-2019
出版日期: 2015年11月11日 內容資訊: 英文 66 Pages
簡介

全球的氣喘和慢性阻塞性肺病等呼吸疾病發病率上升。大約有2億3,500萬人罹患氣喘病,全球有300萬人由於慢性阻塞性肺病死亡。全球呼吸疾病檢驗市場預計2014∼2019年以年複合成長率7.46%擴大。

本報告提供全球呼吸疾病檢驗市場相關調查、各地區趨勢、今後的市場成長前景、2019年的市場規模預測、市場成長的課題、主要供應商趨勢等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 市場環境

  • 市場概要
  • 波特的五力分析

第6章 各檢查市場區隔

第7章 各機器、篩檢檢查市場區隔

第8章 各IVD檢查市場區隔

第9章 各地區市場區隔

第10章 推動市場的要素

  • 慢性呼吸疾病擴大
  • 大氣污染的增加
  • 香煙消費量的增加
  • 醫療服務改善之政府的配合

第11章 促進要素的影響

第12章 市場課題

  • 使用成本效益高的產品
  • 產品設計中的生物適合性的問題
  • 標準的治療與資金的不足
  • 最高限價的壓力

第13章 促進要素與課題的影響

第14章 市場趨勢

  • 擴大認識的舉措與計劃
  • 複合設備的使用
  • 可攜式裝置
  • POC設備的人氣

第15章 供應商環境

  • 競爭模式
  • 關注的供應商
  • 其他值得注意的供應商

第16章 主要供應商分析

  • Alere
  • CareFusion
  • 日本光電工業株式會社
  • Philips Healthcare
  • Smiths Medical

第17章 附錄

第18章 關於Techvavio

圖表

目錄
Product Code: IRTNTR7885

About respiratory disease testing

The respiratory system of the body plays a vital role in eliminating carbon dioxide and toxic wastes, regulates the temperature, and establishes a stabilized blood acid-alkaline balance. Respiratory diseases such as asthma, bronchitis, COPD occur due to acute or chronic defects in the respiratory system. The respiratory testing devices help in detecting chronic or acute respiratory diseases; therefore, the necessary treatment can be provided to people suffering from respiratory damages.

Respiratory tests such as imaging, spirometry, peak flow test, blood gas test, lung volume, and few other tests are used to diagnose the respiratory disease. Globally, there has been growing incidences of respiratory diseases such as asthma and COPD. Around 235 million people globally are suffering from asthma, and there have been around 3 million deaths worldwide due to COPD. This indicates an alarming increase in the respiratory disorders worldwide due to high pollution and increased tobacco consumption.

These factors result in increased demand for the respiratory testing devices and propel the market growth.

Technavio's analysts forecast the global respiratory disease testing market to grow at a CAGR of 7.46% over the period 2014-2019.

Covered in this report

The report covers the current scenario and the growth prospects of the global respiratory disease testing market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of testing devices used to diagnose acute and chronic respiratory diseases.

The market is segmented based on the type of test:

  • Mechanical/screening tests
  • Spirometry test
  • Peak flow test
  • Blood gas test
  • Lung volume test
  • OSA diagnostic tests
  • IVD tests
  • Molecular diagnostic test
  • POC test
  • Others

Technavio's report, Global Respiratory Disease Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, EMEA, and APAC; it also covers the landscape of the global respiratory disease testing market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • Alere
  • CareFusion
  • Nihon Kohden
  • Philips Healthcare
  • Smiths Medical

Other Prominent Vendors

  • Abbott
  • Affymetrix
  • Cepheid
  • COSMED
  • Covidien
  • F. Hoffmann-La Roche
  • Futuremed America
  • Instrumentation Laboratories
  • ndd Medical Technology
  • SDI Diagnostics
  • Seegene
  • Siemens Healthcare

Key market driver

  • Increase in respiratory disorders worldwide
  • For a full, detailed list, view our report

Key market challenge

  • Use of low-cost testing products
  • For a full, detailed list, view our report

Key market trend

  • Initiatives and programs to create awareness
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Five forces analysis

PART 06: Market segmentation by test

PART 07: Market segmentation by mechanical and screening test

  • Market size and forecast

PART 08: Market segmentation by IVD test

  • Molecular diagnostic tests
  • POC tests
  • Other tests

PART 09: Geographical segmentation

  • Global respiratory testing market segmentation by geography

PART 10: Market drivers

  • Prevalence of chronic respiratory diseases
  • Rise in air pollution
  • Increased consumption of tobacco
  • Government measures for improving healthcare services

PART 11: Impact of drivers

PART 12: Market challenges

  • Use of cost-effective products
  • Biocompatibility complications during product design
  • Lack of standard procedure and funds
  • Pricing pressure through price ceilings

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Initiatives and programs to spread awareness
  • Use of multiplex devices
  • Preference for portable devices
  • Popularity of POC devices

PART 15: Vendor landscape

  • Competitive scenario
  • Key prominent vendors
  • Other prominent vendors

PART 16: Key vendor analysis

  • Alere
  • CareFusion
  • Nihon Kohden
  • Philips Healthcare
  • Smiths Medical

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Overview of global respiratory disease testing market
  • Exhibit 03: Global respiratory disease testing market 2014-2019 ($ billions)
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Global respiratory disease testing market by test
  • Exhibit 06: Global respiratory disease testing market by test type 2014
  • Exhibit 07: Global respiratory disease testing market by mechanical and screening test 2014-2019 ($ billions)
  • Exhibit 08: Global respiratory disease testing market by spirometry 2014-2019 ($ millions)
  • Exhibit 09: Global respiratory disease testing market by peak flow test 2014-2019 ($ millions)
  • Exhibit 10: Global respiratory disease testing market by blood gas test 2014-2019 ($ millions)
  • Exhibit 11: Global respiratory disease testing market by pulmonary function test 2014-2019 ($ millions)
  • Exhibit 12: Global respiratory disease testing market by OSA diagnostic test 2014-2019 ($ millions)
  • Exhibit 13: Global respiratory disease testing market by IVD test 2014
  • Exhibit 14: Global respiratory disease testing market segmentation by geography 2014
  • Exhibit 15: Respiratory disease testing market in Americas 2014-2019 ($ billions)
  • Exhibit 16: Respiratory disease testing market in EMEA 2014-2019 ($ billions)
  • Exhibit 17: Respiratory disease testing market in APAC 2014-2019 ($ billions)
  • Exhibit 18: Impact of drivers
  • Exhibit 19: Impact of drivers and challenges
  • Exhibit 20: Alere: Key takeaways
  • Exhibit 21: CareFusion: Key takeaways
  • Exhibit 22: Nihon Kohden: Key takeaways
  • Exhibit 23: Philips Healthcare: Key takeaways
  • Exhibit 24: Smiths Medical: Key takeaways
  • Exhibit 25: Alere: Business segmentation by revenue 2014
  • Exhibit 26: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 27: Alere: Geographical segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 28: Nihon Kohden: Business segmentation by revenue 2015
  • Exhibit 29: Nihon Kohden: Business segmentation by revenue 2014 and 2015 ($ millions)
  • Exhibit 30: Nihon Kohden: Geographical segmentation by revenue 2015
  • Exhibit 31: Philips Healthcare: Business segmentation by revenue 2014
  • Exhibit 32: Smiths Medical: Business segmentation by revenue 2014
  • Exhibit 33: Smiths Medical: Business segmentation by revenue 2013 and 2014 ($ billions)
Back to Top